Gene · 10225
CD96: CD96 molecule
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. CD96: CD96 molecule. Genes, record 10225. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/10225
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| P40200 | T-cell surface protein tactile | 585 | 1 | Ensembl, GeneID, HGNC |
Source UniProt
Patents43
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026004568 A | 2026-01-14 | 40657 | P40200 | Espacenet |
| EP 4641201 A2 | 2025-10-29 | 2769 | P40200 | Espacenet |
| EP 4619424 A2 | 2025-09-24 | 96 | P40200 | Espacenet |
| JP 2025529142 A | 2025-09-04 | 848 | P40200 | Espacenet |
| US 12371689 B2 | 2025-07-29 | 848 | P40200 | Espacenet |
| US 12365732 B2 | 2025-07-22 | 1 | P40200 | Espacenet |
| JP 2025517969 A | 2025-06-12 | 2769 | P40200 | Espacenet |
| WO 2025015322 A1 | 2025-01-16 | 9891 | P40200 | Espacenet |
| JP 2024536217 A | 2024-10-04 | 3 | P40200 | Espacenet |
| EP 4408443 A1 | 2024-08-07 | 3 | P40200 | Espacenet |
1 to 10 of 43
See all 43 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants840
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | CD96 papers | Newest fiscal year |
|---|---|---|---|
| P30CA008748 | Cancer Center Support Grant | 10 | 2025 |
| P01CA111412 | NK cells, their receptors and cancer therapy | 8 | 2025 |
| P01CA065493 | Off-the-Shelf Immune Effector Cells for Hematological Malignancies | 7 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 7 | 2025 |
| P30CA006973 | Regional Oncology Research Center | 4 | 2025 |
| P30CA016058 | Cancer Center Support Grant | 4 | 2025 |
| P30CA021765 | Cancer Center Support Grant (CCSG) | 4 | 2025 |
| R01HL117913 | The NOTCH Signaling Pathway in Large Vessel Vasculitis | 4 | 2025 |
| U19AI057229 | Understanding Influenza and SARS-CoV-2 vaccine responses, in vivo and in vitro | 4 | 2025 |
| U19AI057266 | Vaccine and Infection Induced Immunity in the Young and Aged | 4 | 2025 |
1 to 10 of 840Source NIH's project files
See all 840 nih grantsPapers1,736
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Bioinformatics Analysis of T-cell Exhaustion Genes in Pediatric Allergic Rhinitis and their Clinical Diagnostic Significance. | Endocr Metab Immune Disord Drug Targets | 2026 | 42813621 | PubTator, text mining | PubMed |
| Natural Killer Cell-Derived Extracellular Vesicle Preparations Demonstrate Potent Antitumor Activity Against Human Glioblastoma In Vitro and In Vivo. | J Extracell Biol | 2026 | 42788040 | PubTator, text mining | PubMed |
| Immune checkpoint knockout screen reveals TIGIT-CD155 interaction as a significant modulator of adapter CAR-T cell function in acute myeloid leukemia. | Oncoimmunology | 2026 | 42750591 | PubTator, text mining | PubMed |
| Identification of core differentially expressed genes for respiratory syncytial virus infection. | Glob Med Genet | 2026 | 42729716 | PubTator, text mining | PubMed |
| The PVR-TIGIT/CD96/CD226 axis: a novel immune checkpoint target in ovarian cancer. | Front Immunol | 2026 | 42694449 | PubTator, text mining | PubMed |
| A Phase I First-Time-in-Human, Open-label Study of Nelistotug Administered to Patients with Advanced Solid Tumors. | Clin Cancer Res | 2026 | 42658188 | PubTator, text mining | PubMed |
| CD96 marks a phenotypically distinct checkpoint-associated HCV-specific CD8+ T-cell subset featuring memory-associated states. | Front Immunol | 2026 | 42516367 | PubTator, text mining | PubMed |
| A novel Vδ1 engager targeting CD19 enhances human Vδ1 γδ T cell responses against CLL and CD19+ hematological malignancies. | J Immunol | 2026 | 42455847 | PubTator, text mining | PubMed |
| Single-cell RNA Sequencing Reveals A Tumor-Promoting Role of EGR1+CD4+ T Cells in Papillary Thyroid Cancer. | Genomics Proteomics Bioinformatics | 2026 | 42412534 | PubTator, text mining | PubMed |
| Spatial analyses implicate high stromal tumour-infiltrating CD8+ lymphocytes as a negative predictive marker for chemotherapy in estrogen receptor-positive breast cancer. | Nat Commun | 2026 | 42337235 | PubTator, text mining | PubMed |
1 to 10 of 1,736
See all 1,736 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/10225
GET https://conductscience.org/api/genes/v1/10225/patents?page=2